Study of innate immunity in primary antibody deficiency

  • 金兼, 弘和 (Principal Investigator)
  • 石川, 文彦 (Co-Investigator(Renkei-kenkyūsha))

Project Details

Abstract

Approximately 15-20% of patients with X-linked agammaglobulinemia(XLA), which is caused by BTK deficiency, have neutropenia, and it is associated with the severity of infection. BTK-deficient neutrophils had more production of reactive oxygen species(ROS) after various stimuli, which was associated with more apoptosis. The production of ROS and apoptosis of BTK-deficient neutrophils were reversed by transduction of recombinant BTK. These data suggest that severe neutropenia in patients with XLA can be treated with recombinant BTK.
StatusFinished
Effective start/end date2009/01/012011/12/31

Funding

  • Japan Society for the Promotion of Science: ¥4,420,000.00

Keywords

  • 抗体産生不全症
  • 自然免疫
  • X連鎖無ガンマグロブリン血症
  • Toll様受容体
  • ブルトンチロシンキナーゼ